Trial
NCT03347526
A Novel Approach to Infantile Spasms
Phase IIISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
Pediatric Epilepsy Research Foundation; West Therapuetics, Inc
Condition
Infantile Spasm
Intervention
Cosyntropin Injectable Suspension, 1 mg/mL
Why stopped
Study on enrollment hold as a precaution per the pharmaceutical company.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-27